Bookmark

Add to MyYahoo RSS

DePuy Orthopaedics News

News on DePuy Orthopaedics (Ticker: JNJ) continually updated from thousands of sources around the net.

5 hrs ago | Hispanic Business

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2014

We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls, LOC-AID Technologies, Medical Equipment, Hospital Administration, St Peters Health Care Services

Tue Jul 22, 2014

The Motley Fool

3 Quotes From Johnson & Johnson's Conference Call You Need to Read

Here are three quotes from the call and some commentary about why they're so important.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mon Jul 21, 2014

TheStreet.com

Johnson & Johnson (JNJ) Declares 70c Quarterly Dividend

The quarterly dividend is in line with the company's previous. The dividend is payable on Sept.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Jul 16, 2014

AmericanBankingNews.com

Johnson & Johnson Given "Neutral" Rating at Zacks

's stock had its "neutral" rating reaffirmed by Zacks in a note issued to investors on Wednesday.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Forbes.com

Johnson & Johnson Earnings: New Blockbuster Drug Olysio Lifts Sales But May Face Competition Soon

Johnson & Johnson recently released its second quarter results. While the company beat consensus estimates, its stock fell slightly due to a weaker-than-expected outlook for the second half of 2014.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Morningstar

J&J's Strong 2Q Led by Pharmaceuticals

Johnson & Johnson reported strong second-quarter results that exceeded both our and consensus expectations largely because of stronger-than-expected pharmaceutical sales.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

CNN

Americans stock up on Tylenol, baby products

Americans have also been stocking up on anti-smoking aids, baby products, Aveeno skin care products and even Listerine mouthwash, according to the company.

Comment?

Related Topix: Smoking, Medicine, Health, Johnson & Johnson, Biotech, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Medical Equipment, Hospital Administration, St Peters Health Care Services

Tue Jul 15, 2014

TheStreet.com

Johnson & Johnson Beats on EPS but Sags on a Technical Basis

The large-cap pharmaceutical company also beat on revenue and raised full-year guidance.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

HAPPI/Household & PP Industry

Q2 Sales Rise at J&J

Johnson & Johnson posted a 9.1% increase in sales of $19.5 billion for the second quarter of 2014.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Medical Equipment, Hospital Administration, St Peters Health Care Services

Reuters

J&J beats forecasts, helped by new hepatitis C drug

Johnson & Johnson reported sharply better-than-expected quarterly revenue and earnings, fueled by strong sales of newer prescription drugs, including its Olysio treatment for hepatitis C. The diversified healthcare company on Tuesday said it earned $4.33 billion, or $1.51 per share, in the second quarter.

Comment?

Related Topix: Food, J and J Snack Foods, Hepatitis, Medicine, Health, Johnson & Johnson, Biotech, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Medical Equipment

AmericanBankingNews.com

Tues., July 15: Hewlett-Packard Among Stocks to Watch

WSJ's Polya Lesova joins Simon Constable on the News Hub to discuss why investors are eyeing Hewlett-Packard, Reynolds American and Johnson & Johnson stock.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

The Modesto Bee

J&J 2Q profit climbs 13 percent

The New Brunswick, New Jersey-based company said earnings increased to $4.33 billion, or $1.51 per share, from $3.83 billion, or $1.33 per share, in the same quarter a year ago.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mon Jul 14, 2014

The Motley Fool

Earnings Preview: Abbott Laboratories and Johnson & Johnson

The health care sector in general, and biotech industry in particular, have now shrugged off their earlier first quarter dip.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

AmericanBankingNews.com

Johnson & Johnson (JNJ) to Release Earnings on Tuesday

Johnson & Johnson is set to release its Q214 earnings data on Tuesday, July 15th.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Fri Jul 11, 2014

Insider Monkey

How Pharma Majors like Pfizer Inc. (PFE), Johnson & Johnson (JNJ) And ...

CNBC's Meg Tirrell reported on the popular "Squawk Box" program that patients suffering from Alzheimer disease in U.S and across the globe are assuming epidemic proportions with "5 million people currently have Alzheimer's in the united states" alone and has been estimated to have been the "sixth leading cause of death" in the country.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Pfizer, Medical Equipment, Hospital Administration, St Peters Health Care Services

Forbes.com

Johnson & Johnson Earnings Should Show Pharma Buisness To Remain Strong

Johnson & Johnson will report its Q2 2014 earnings on July 15. We expect no significant change in the intensity of the main trends driving the company's business .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment, Hospital Administration, St Peters Health Care Services

LongIsland.com

First State Investigation Into Questionable Marketing Tactics Ends in ...

July 11th, 2014 - The state of Oregon launched an investigation into whether or not DePuy Orthopaedics, the manufacturer of now-recalled ASR metal-on-metal hip replacement devices , engaged in deceptive marketing practices by recommending the defective implants to residents of the state who were in need of hip replacement surgery.

Comment?

Related Topix: Marketing, Oregon, Oregon Government, Medicine, Medical Equipment, Healthcare Industry, Biotech, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals

The Motley Fool

Today's Top Biotech Stocks to Watch: Johnson & Johnson and Sarepta Therapeutics

Let's take a look at today's top stories in biotech and health care. Keep an eye out for Johnson & Johnson ( Analysts are optimistic about Johnson & Johnson's second quarter earnings With J&J set to reveal second quarter earnings next Tuesday, July 15, Wall Street analysts are predicting that the company will beat consensus earnings per share of ... (more)

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Jul 09, 2014

The Motley Fool

Is Pharmacyclics the Next Celgene?

Revlimid notched label expansions for use in multiple myeloma in 2006 and mantle cell lymphoma in 2013.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mon Jul 07, 2014

The Motley Fool

The Dow Breaks Its Streak but Holds 17,000 as Johnson & Johnson and AT&T Rise

Yet even as nervous investors took profits after weighing the potential for future gains against the risk involved in the stock market, the Dow still managed to hang onto the 17,000 level.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••